In the case of an APL patient with a relapse, WT1 gene expression was dramatically downregulated to an undetectable level after 7.5 months of treatment (Figure 6B), when molecular remission was achieved (PML-RAR alpha mRNA was negative/<0.001%). Here, WT1 is linked to acute promyelocytic leukemia.